ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2021)
Varn, Frederick; Johnson, Kevin; Wade, Taylor; Malta, Tathiane; Sabedot, Thais; Barthel, Floris; Kim, Hoon; Ahmed, Nazia; Dalta, Indrani; Noushmehr, Houtan
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting & Education Day of the Society for Neuro-Oncology. Unidades: FMRP, FCFRP
Assuntos: GLIOMA, PROGNÓSTICO, SEQUÊNCIA DO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VARN, Frederick et al. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noab196.008. Acesso em: 30 ago. 2024. , 2021
APA
Varn, F., Johnson, K., Wade, T., Malta, T., Sabedot, T., Barthel, F., et al. (2021). Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noab196.008
NLM
Varn F, Johnson K, Wade T, Malta T, Sabedot T, Barthel F, Kim H, Ahmed N, Dalta I, Noushmehr H. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment [Internet]. Neuro-Oncology. 2021 ; 23 vi3.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noab196.008
Vancouver
Varn F, Johnson K, Wade T, Malta T, Sabedot T, Barthel F, Kim H, Ahmed N, Dalta I, Noushmehr H. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment [Internet]. Neuro-Oncology. 2021 ; 23 vi3.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noab196.008
Trabalho de evento-resumo periodico
Glioma cell-free DNA methylation marker for diagnosis and monitoring (2020)
Sabedot, Thais; Malta, Tathiane Maistro; Snyder, James; Nelson, Kevin; Wells, Michael; Carvalho, Ana de; Mukherjee, Abir; Chitale, Dhan; Mosella, Maritza Queiroz Salas ; Castro, Ana Valéria; Noushmehr, Houtan
Fonte: Clinical Cancer Research. Nome do evento: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Assuntos: BIOMARCADORES, METILAÇÃO DE DNA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais et al. Glioma cell-free DNA methylation marker for diagnosis and monitoring. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A10. Acesso em: 30 ago. 2024. , 2020
APA
Sabedot, T., Malta, T. M., Snyder, J., Nelson, K., Wells, M., Carvalho, A. de, et al. (2020). Glioma cell-free DNA methylation marker for diagnosis and monitoring. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A10
NLM
Sabedot T, Malta TM, Snyder J, Nelson K, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella MQS, Castro AV, Noushmehr H. Glioma cell-free DNA methylation marker for diagnosis and monitoring [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A10
Vancouver
Sabedot T, Malta TM, Snyder J, Nelson K, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella MQS, Castro AV, Noushmehr H. Glioma cell-free DNA methylation marker for diagnosis and monitoring [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A10
Trabalho de evento-resumo periodico
DNA methylation-based liquid biopsy detects primary and recurrent meningioma (2020)
Sabedot, Thais Sarraf; Malta, Tathiane M.; Snyder, James; Walbert, Tobias; Lee, Ian; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Fonte: Clinical Cancer Research. Nome do evento: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Assuntos: BIÓPSIA, METILAÇÃO DE DNA, MENINGIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais Sarraf et al. DNA methylation-based liquid biopsy detects primary and recurrent meningioma. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A12. Acesso em: 30 ago. 2024. , 2020
APA
Sabedot, T. S., Malta, T. M., Snyder, J., Walbert, T., Lee, I., Kalkanis, S., et al. (2020). DNA methylation-based liquid biopsy detects primary and recurrent meningioma. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A12
NLM
Sabedot TS, Malta TM, Snyder J, Walbert T, Lee I, Kalkanis S, Castro AV, Noushmehr H. DNA methylation-based liquid biopsy detects primary and recurrent meningioma [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A12
Vancouver
Sabedot TS, Malta TM, Snyder J, Walbert T, Lee I, Kalkanis S, Castro AV, Noushmehr H. DNA methylation-based liquid biopsy detects primary and recurrent meningioma [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A12
Trabalho de evento-resumo periodico
Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features (2020)
Wells, Michael; Asmaro, karam; Sabedot, Thais; Mosella, Maritza Queiroz Salas ; Malta, Tathiane; Nelson, Kevin; Snyder, James; Kalkanis, Steven; Castro, Ana Valéria; Noushmehr, Houtan
Fonte: Clinical Cancer Research. Nome do evento: AACR Special Conference on Advances in Liquid Biopsies. Unidade: FMRP
Assuntos: METILAÇÃO DE DNA, GLÂNDULA PITUITÁRIA, NEOPLASIAS, BIÓPSIA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WELLS, Michael et al. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1557-3265.LiqBiop20-A11. Acesso em: 30 ago. 2024. , 2020
APA
Wells, M., Asmaro, karam, Sabedot, T., Mosella, M. Q. S., Malta, T., Nelson, K., et al. (2020). Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features. Clinical Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1557-3265.LiqBiop20-A11
NLM
Wells M, Asmaro karam, Sabedot T, Mosella MQS, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A11
Vancouver
Wells M, Asmaro karam, Sabedot T, Mosella MQS, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features [Internet]. Clinical Cancer Research. 2020 ; 26( 11):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1557-3265.LiqBiop20-A11
Trabalho de evento-resumo periodico
Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype (2019)
Malta, T.; Sabedot, T.; Lee, I.; Wells, M.; Castro, A.; Noushmehr, Houtan
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: NEOPLASIAS DO SISTEMA NERVOSO, MENINGIOMA, CROMATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, T. et al. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.058. Acesso em: 30 ago. 2024. , 2019
APA
Malta, T., Sabedot, T., Lee, I., Wells, M., Castro, A., & Noushmehr, H. (2019). Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.058
NLM
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype [Internet]. Neuro-Oncology. 2019 ; 21 iii7.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz126.058
Vancouver
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype [Internet]. Neuro-Oncology. 2019 ; 21 iii7.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz126.058
Trabalho de evento-resumo periodico
DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors (2019)
Mosella, Maritza Queiroz Salas ; Sabedot, Thais Sarraf; Malta, Tathiane Maistro; Rock, J.; Felicella, M.; Aho, T.; Noushmehr, Houtan ; Castro, A. V.
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: GLÂNDULA PITUITÁRIA, TUMOR CARCINOIDE, METILAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOSELLA, Maritza Queiroz Salas et al. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.236. Acesso em: 30 ago. 2024. , 2019
APA
Mosella, M. Q. S., Sabedot, T. S., Malta, T. M., Rock, J., Felicella, M., Aho, T., et al. (2019). DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.236
NLM
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii65.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz126.236
Vancouver
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii65.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz126.236
Trabalho de evento-resumo periodico
Non-invasive prediction of glioma tumor stemness using multimodal MRI (2019)
Davoodi-Bojd, Esmaeil; Malta, Tathiane; Griffith, Brent; Snyder, James; Walbert, Tobias; Noushmehr, Houtan ; Soltanian-Zadeh, Hamid
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: GLIOMA, TUMOR CARCINOIDE, RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVOODI-BOJD, Esmaeil et al. Non-invasive prediction of glioma tumor stemness using multimodal MRI. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-1939. Acesso em: 30 ago. 2024. , 2019
APA
Davoodi-Bojd, E., Malta, T., Griffith, B., Snyder, J., Walbert, T., Noushmehr, H., & Soltanian-Zadeh, H. (2019). Non-invasive prediction of glioma tumor stemness using multimodal MRI. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-1939
NLM
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Non-invasive prediction of glioma tumor stemness using multimodal MRI [Internet]. Cancer Research. 2019 ; 79( 13): 1939.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1939
Vancouver
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Non-invasive prediction of glioma tumor stemness using multimodal MRI [Internet]. Cancer Research. 2019 ; 79( 13): 1939.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-1939
Trabalho de evento-resumo periodico
Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors (2019)
Castro, Ana Valéria; Wells, M.; Asmaro, K.; Sabedot, T. S.; Mosella, M. S.; Malta, T. M.; Nelson, K.; Snyder, J.; Carvalho, A. de; Noushmehr, Houtan
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: TUMOR CARCINOIDE, GLÂNDULA PITUITÁRIA, MARCADOR MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Ana Valéria et al. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz126.080. Acesso em: 30 ago. 2024. , 2019
APA
Castro, A. V., Wells, M., Asmaro, K., Sabedot, T. S., Mosella, M. S., Malta, T. M., et al. (2019). Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz126.080
NLM
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz126.080
Vancouver
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, Carvalho A de, Noushmehr H. Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors [Internet]. Neuro-Oncology. 2019 ; 21 iii24.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz126.080
Trabalho de evento-resumo periodico
Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers (2019)
Noushmehr, Houtan ; Sabedot, T.; Malta, T.; Nelson, K.; Snyder, J.; Wells, M.; Carvalho, A. de; Mukherjee, A.; Chitale, D.; Mosella, M.
Fonte: Neuro-Oncology. Nome do evento: Annual Meeting European Association of Neuro-Oncology - EANO. Unidade: FMRP
Assuntos: GLIOMA, MARCADOR MOLECULAR, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMEHR, Houtan et al. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1101/601245. Acesso em: 30 ago. 2024. , 2019
APA
Noushmehr, H., Sabedot, T., Malta, T., Nelson, K., Snyder, J., Wells, M., et al. (2019). Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1101/601245
NLM
Noushmehr H, Sabedot T, Malta T, Nelson K, Snyder J, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella M. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers [Internet]. Neuro-Oncology. 2019 ; 21 iii6.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1101/601245
Vancouver
Noushmehr H, Sabedot T, Malta T, Nelson K, Snyder J, Wells M, Carvalho A de, Mukherjee A, Chitale D, Mosella M. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers [Internet]. Neuro-Oncology. 2019 ; 21 iii6.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1101/601245
Trabalho de evento-resumo periodico
Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer (2019)
Sabedot, Thais S.; Cassel, Seth H.; Gao, Galen F.; Lareau, Caleb A.; Chernniak, Andrew; Lazar, Alexander; Kadoch, Cigall; Noushmehr, Houtan
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: BIOINFORMÁTICA, EPIGÊNESE GENÉTICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABEDOT, Thais S. et al. Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-907. Acesso em: 30 ago. 2024. , 2019
APA
Sabedot, T. S., Cassel, S. H., Gao, G. F., Lareau, C. A., Chernniak, A., Lazar, A., et al. (2019). Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-907
NLM
Sabedot TS, Cassel SH, Gao GF, Lareau CA, Chernniak A, Lazar A, Kadoch C, Noushmehr H. Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer [Internet]. Cancer Research. 2019 ; 79( 13):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-907
Vancouver
Sabedot TS, Cassel SH, Gao GF, Lareau CA, Chernniak A, Lazar A, Kadoch C, Noushmehr H. Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer [Internet]. Cancer Research. 2019 ; 79( 13):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-907
Trabalho de evento-resumo periodico
Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas (2019)
Noushmehr, Houtan ; Sabedot, Thais S.; Malta, Tathiane M.; Nelson, Kevin K.; Snyder, James; Wells, Michael; Mosella, Maritza S.; Carvalho, Ana de; Asmaro, karam; Scarpace, Lisa; Robin, Adam M.; Rosenblum, Mark L.; Mikkelsen, Tom; Rock, Jack; Walbert, Tobias; Lee, Ian; Poisson, Laila M.; Kalkanis, Steven N.; Castro, Ana V.
Fonte: Cancer Research. Nome do evento: Annual Meeting American Association for Cancer Research - AACR. Unidade: FMRP
Assuntos: NEOPLASIAS OVARIANAS, GENÉTICA MÉDICA, TUMOR CARCINOIDE, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOUSHMEHR, Houtan et al. Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2019-LB-234. Acesso em: 30 ago. 2024. , 2019
APA
Noushmehr, H., Sabedot, T. S., Malta, T. M., Nelson, K. K., Snyder, J., Wells, M., et al. (2019). Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2019-LB-234
NLM
Noushmehr H, Sabedot TS, Malta TM, Nelson KK, Snyder J, Wells M, Mosella MS, Carvalho A de, Asmaro karam, Scarpace L, Robin AM, Rosenblum ML, Mikkelsen T, Rock J, Walbert T, Lee I, Poisson LM, Kalkanis SN, Castro AV. Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas [Internet]. Cancer Research. 2019 ; 79( 13): .[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-LB-234
Vancouver
Noushmehr H, Sabedot TS, Malta TM, Nelson KK, Snyder J, Wells M, Mosella MS, Carvalho A de, Asmaro karam, Scarpace L, Robin AM, Rosenblum ML, Mikkelsen T, Rock J, Walbert T, Lee I, Poisson LM, Kalkanis SN, Castro AV. Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas [Internet]. Cancer Research. 2019 ; 79( 13): .[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2019-LB-234
Trabalho de evento-resumo periodico
Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification (2019)
Ng, Hon Keung; Li, Kay Ka-Wai; Malta, Tathiane M.; Shi, Zhi-feng; Noushmehr, Houtan
Fonte: Neuro-Oncology. Nome do evento: Annual Conference British Neuro-Oncology Society - BNOS. Unidade: FMRP
Assuntos: EPIGÊNESE GENÉTICA, NEOPLASIAS CEREBRAIS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NG, Hon Keung et al. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noz167.006. Acesso em: 30 ago. 2024. , 2019
APA
Ng, H. K., Li, K. K. -W., Malta, T. M., Shi, Z. -feng, & Noushmehr, H. (2019). Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noz167.006
NLM
Ng HK, Li KK-W, Malta TM, Shi Z-feng, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification [Internet]. Neuro-Oncology. 2019 ; 21 iv2.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz167.006
Vancouver
Ng HK, Li KK-W, Malta TM, Shi Z-feng, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification [Internet]. Neuro-Oncology. 2019 ; 21 iv2.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1093/neuonc/noz167.006
Trabalho de evento-resumo periodico
DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma (2018)
Bhan, A.; Mosella, M. S.; Singer, M.; Keller, C. E.; Shaar, R. Abou; Chang, S.; Wu, V.; Stephen, J.; Worsham, M.; Noushmehr, Houtan
Fonte: Thyroid. Nome do evento: Annual Meeting of the American Thyroid Association. Unidade: FMRP
Assuntos: NEOPLASIAS DA TIREOIDE, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHAN, A. et al. DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma. Thyroid. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1089/thy.2018.29065.abstracts. Acesso em: 30 ago. 2024. , 2018
APA
Bhan, A., Mosella, M. S., Singer, M., Keller, C. E., Shaar, R. A., Chang, S., et al. (2018). DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma. Thyroid. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1089/thy.2018.29065.abstracts
NLM
Bhan A, Mosella MS, Singer M, Keller CE, Shaar RA, Chang S, Wu V, Stephen J, Worsham M, Noushmehr H. DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma [Internet]. Thyroid. 2018 ; 28 A-24.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1089/thy.2018.29065.abstracts
Vancouver
Bhan A, Mosella MS, Singer M, Keller CE, Shaar RA, Chang S, Wu V, Stephen J, Worsham M, Noushmehr H. DNA methylation signature associated with risk of recurrence in papillary thyroid carcinoma [Internet]. Thyroid. 2018 ; 28 A-24.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1089/thy.2018.29065.abstracts
Artigo de periodico
Machine learning identifies stemness features associated with oncogenic dedifferentiation (2018)
Malta, Tathiane M.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Fonte: Cell. Unidade: FMRP
Assuntos: GENÔMICA, NEOPLASIAS, CÉLULAS-TRONCO, APRENDIZADO COMPUTACIONAL, ALGORITMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell, v. 173, n. 2, p. 338-354.e1-e5, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.03.034. Acesso em: 30 ago. 2024.
APA
Malta, T. M., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell, 173( 2), 338-354.e1-e5. doi:10.1016/j.cell.2018.03.034
NLM
Malta TM, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Machine learning identifies stemness features associated with oncogenic dedifferentiation [Internet]. Cell. 2018 ; 173( 2): 338-354.e1-e5.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.cell.2018.03.034
Vancouver
Malta TM, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Machine learning identifies stemness features associated with oncogenic dedifferentiation [Internet]. Cell. 2018 ; 173( 2): 338-354.e1-e5.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.cell.2018.03.034
Trabalho de evento-resumo periodico
Comprehensive analysis of cancer stemness (2018)
Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; Burzykowski, Tomasz; Poisson, Laila; Weinstein, John; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Noushmehr, Houtan
Fonte: Cancer Research. Nome do evento: Annual Meeting of the American Association for Cancer Research (AACR). Unidade: FMRP
Assuntos: NEOPLASIAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTA, Tathiane M. et al. Comprehensive analysis of cancer stemness. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2018-LB-373. Acesso em: 30 ago. 2024. , 2018
APA
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J., et al. (2018). Comprehensive analysis of cancer stemness. Cancer Research. Baltimore: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2018-LB-373
NLM
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein J, Kaminska B, Huelsken J, Omberg L, Gevaert O, Noushmehr H. Comprehensive analysis of cancer stemness [Internet]. Cancer Research. 2018 ; 78( 13):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2018-LB-373
Vancouver
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein J, Kaminska B, Huelsken J, Omberg L, Gevaert O, Noushmehr H. Comprehensive analysis of cancer stemness [Internet]. Cancer Research. 2018 ; 78( 13):[citado 2024 ago. 30 ] Available from: https://doi.org/10.1158/1538-7445.AM2018-LB-373
Artigo de periodico
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1 (2017)
Mazor, Tali; Chesnelong, Charles; Pankov, Aleksandr; Jalbert, Llewellyn E.; Hong, Chibo; Hayes, Josie; Smirnov, Ivan V.; Marshall, Roxanne; Souza, Camila F.; Shen, Yaoqing; Viswanath, Pavithra; Noushmehr, Houtan
Fonte: Proceedings of the National Academy of Sciences. Unidade: FMRP
Assuntos: METILAÇÃO DE DNA, GLIOMA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZOR, Tali et al. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proceedings of the National Academy of Sciences, v. 114, n. 40, p. 10743-10748, 2017Tradução . . Disponível em: https://doi.org/10.1073/pnas.1708914114. Acesso em: 30 ago. 2024.
APA
Mazor, T., Chesnelong, C., Pankov, A., Jalbert, L. E., Hong, C., Hayes, J., et al. (2017). Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proceedings of the National Academy of Sciences, 114( 40), 10743-10748. doi:10.1073/pnas.1708914114
NLM
Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1 [Internet]. Proceedings of the National Academy of Sciences. 2017 ; 114( 40): 10743-10748.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1073/pnas.1708914114
Vancouver
Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1 [Internet]. Proceedings of the National Academy of Sciences. 2017 ; 114( 40): 10743-10748.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1073/pnas.1708914114

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Nome do evento

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada